Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)

Exclusion Criteria

• •Patient with severe congenital abnormalities
• •Patient with antenatal brain hemorrhage
• •Patient with asphyxia or Hypoxic ischemic encepalophathy
• •Patient with chromosome anomalies (i.e. Edward syndrome, Patau syndrome, Down syndrome, etc) or severe congenital malformation (Hydrocephalus, Encephalocele, etc)
• •Patient with a concurrent severe congenital infection (i.e. Herpes, Toxoplasmosis, Rubella, Syphilis, AIDS, etc)
• •Patient withCRP \> 30 mg/dL; Severe sepsis or shock
• •Patient with a history of participating in other clinical studies
• •Patient who is considered inappropriate to participate in the study by the investigator